These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1325926)

  • 21. Gene expressions associated with chemosensitivity in human hepatoma cells.
    Hoshida Y; Moriyama M; Otsuka M; Kato N; Taniguchi H; Shiratori Y; Seki N; Omata M
    Hepatogastroenterology; 2007 Mar; 54(74):489-92. PubMed ID: 17523305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
    Hung WC; Chuang LY
    Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells.
    Guan HG; Xue WJ; Qian HX; Zhou XJ; Qin L; Lan J
    Chin Med J (Engl); 2009 Jun; 122(11):1328-32. PubMed ID: 19567146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.
    Yokomizo A; Ono M; Nanri H; Makino Y; Ohga T; Wada M; Okamoto T; Yodoi J; Kuwano M; Kohno K
    Cancer Res; 1995 Oct; 55(19):4293-6. PubMed ID: 7671238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells.
    Gupta V; Costanzi JJ
    Cancer Res; 1987 May; 47(9):2407-12. PubMed ID: 2436764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.
    Kawahara N; Tanaka T; Yokomizo A; Nanri H; Ono M; Wada M; Kohno K; Takenaka K; Sugimachi K; Kuwano M
    Cancer Res; 1996 Dec; 56(23):5330-3. PubMed ID: 8968078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro testing of chemosensitivity in physiological hypoxia.
    Grigoryan R; Keshelava N; Anderson C; Reynolds CP
    Methods Mol Med; 2005; 110():87-100. PubMed ID: 15901930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Okamura M; Shimada J; Sakagami H
    Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.
    Jiang S; Song MJ; Shin EC; Lee MO; Kim SJ; Park JH
    Hepatology; 1999 Jan; 29(1):101-10. PubMed ID: 9862856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
    Berti E; Carrara M; Ragazzi E; D'Ancona S; Berti T
    Int J Oncol; 1999 Jul; 15(1):155-60. PubMed ID: 10375609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
    Ning SC; Hahn GM
    Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
    Inoue H; Miyazono N; Hori A; Kanetsuki I; Tanaka D; Fukukura Y; Tsuchimochi S; Hokotate H; Ida K; Ikeda K
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1049-53. PubMed ID: 8390227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
    Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
    Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effects of geldanamycin and antitumor drugs.
    Liao ZY; Zhang SH; Zhen YS
    Yao Xue Xue Bao; 2001 Aug; 36(8):569-75. PubMed ID: 12579931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs.
    Barranco SC; Haenelt BR; Gee EL
    Cancer Res; 1978 Mar; 38(3):656-60. PubMed ID: 75057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.